Featured Research

from universities, journals, and other organizations

Treating Safety Research Like Other Clinical Studies Slows Progress

Date:
May 13, 2008
Source:
Johns Hopkins Medical Institutions
Summary:
Progress in patient safety research could slow to a crawl unless regulators work out a host of ethical issues, Johns Hopkins researchers assert in an upcoming opinion piece.

Progress in patient safety research could slow to a crawl unless regulators work out a host of ethical issues, Johns Hopkins researchers assert in an upcoming opinion piece.

"We can't apply a clinical paradigm to patient safety research. It just isn't the right fit," says Nancy Kass, Sc.D., deputy director for public health at the Johns Hopkins Berman Institute of Bioethics and an author of the article.

The piece, published in the June issue of The Joint Commission Journal on Quality and Patient Safety, was sparked by a 2006 study led by Peter Pronovost, M.D., Ph.D., professor of anesthesiology, critical care medicine, and surgery at the Johns Hopkins University School of Medicine. In the study, Pronovost, an expert on patient safety, implemented a checklist in intensive care units (ICUs) at 67 Michigan hospitals aimed at preventing bloodstream infections whenever doctors insert catheters.

The results were markedly positive: Bloodstream infections from catheters fell by two-thirds, and on average, infection rates in the ICUs went from 4 percent to zero. Over the course of the study, the program saved more than 1,500 lives and nearly $200 million.

Shortly after the study's results were published, however, an anonymous complaint led to a federal reexamination of the ethical oversight of the study. As in most human research, Pronovost's study had been reviewed by an institutional review board (IRB)-an internal group required at most research institutions to use federal regulations to make sure research studies protect the welfare of human subjects.

Because Pronovost's study enforced safety measures already known to be effective, and because no data were ever collected from patients by name, the Johns Hopkins IRB classified Pronovost's study as "exempt" from further IRB review. This designation meant that informed consent was not necessary from the ICU patients and that IRB review from each of the 67 Michigan hospitals that participated wasn't required. However, after the anonymous complaint, the federal Office for Human Research Protections, a branch of the U.S. Department of Health and Human Services that oversees IRBs, determined that patient consent and Michigan hospital IRB review should have taken place.

According to Kass, who served for more than 10 years on a Johns Hopkins IRB and is an expert in the ethics of human research, such a decision ignores the differences between patient safety research of this sort and other types of research that include riskier and more burdensome interventions and procedures, such as human trials for new drugs.

While well-informed consent is crucial for all patients participating in new drug research, for example, it may not be necessary for studies like Pronovost's research, in which the proposed intervention-a checklist to remember to follow steps, all known to make the ICU safer-is virtually risk-free, where data are lumped together so individual patients' names and information are never collected, and where the consent process may be burdensome to very sick patients. Also, according to Kass, since many small hospitals don't have IRBs, requiring every hospital to get an IRB review for patient safety evaluations would hinder many hospitals from participating in these studies and contributing their experiences to widespread evaluations.

"All of us want to make sure that patients are protected in any type of research," said Kass, "but it is also critical to recognize which studies are low risk and should easily move through the system, and which ones are high risk and require considerably more scrutiny."

Kass adds that working through these issues is crucial to advancing patient safety research, a field that has the potential to greatly advance public health.

"When the public thinks about important medical research, they might think about a cure for a horrible disease. I think the average person has heard very little about the fact that many more people die in the hospital of medical errors than they do from lots of diseases," she says.

"There is an ethical imperative to do patient safety research," she adds. "We need to find a review system that works so that important research in this field won't be compromised."

Other authors of the article include Pronovost, leader of the 2006 checklist study; Jeremy Sugarman, M.D., M.P.H., M.A.; Christine A. Goeschel, R.N., M.P.A., M.P.S.; Lisa H. Lubomski, Ph.D.; and Ruth Faden, Ph.D.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Treating Safety Research Like Other Clinical Studies Slows Progress." ScienceDaily. ScienceDaily, 13 May 2008. <www.sciencedaily.com/releases/2008/05/080513153939.htm>.
Johns Hopkins Medical Institutions. (2008, May 13). Treating Safety Research Like Other Clinical Studies Slows Progress. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2008/05/080513153939.htm
Johns Hopkins Medical Institutions. "Treating Safety Research Like Other Clinical Studies Slows Progress." ScienceDaily. www.sciencedaily.com/releases/2008/05/080513153939.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com
Google's Next Frontier: The Human Body

Google's Next Frontier: The Human Body

Newsy (July 27, 2014) Google is collecting genetic and molecular information to paint a picture of the perfectly healthy human. Video provided by Newsy
Powered by NewsLook.com
What's To Blame For Worst Ebola Outbreak In History?

What's To Blame For Worst Ebola Outbreak In History?

Newsy (July 27, 2014) A U.S. doctor has tested positive for the deadly Ebola virus, as the worst-ever outbreak continues to grow. Video provided by Newsy
Powered by NewsLook.com
Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins